REGN
Regeneron Pharmaceuticals, Inc.
NMS
$619.87
+16.95
(+2.81%)
Pullback · -1.74σ
Grade C
132-Day TAO Zones
21 EMA
+1 ATR
+2 ATR
−2 ATR
—
O —
H —
L —
C —
—
—
Key statistics
Mkt cap
$65.0B
P/E ttm
15.1
Fwd P/E
11.5
Beta
0.30
Day range
$619.87
52w range
$591.52 – $821.11
Avg vol
0.8M
RSI(2)
77.9
ROE
14.5%
Net mgn
29.6%
FCF mgn
21.9%
Debt/Eq
0.09
Div yld
—
Sector
Healthcare
Industry
Biotechnology
Next earn
2026-07-30
Matrix setup grades
Long
C
score 34 · tech 34 / 80 · support 0 / 20
KC2 lower, -1.61 ATR from EMA21 · no notable pattern
- · KC2 lower stretch — standard mean-reversion tier
- · RSI hook from oversold (34)
- · Stochastic bull cross in oversold
Short
—
score 16 · tech 16 / 80 · support 0 / 20
below KC1 upper, -1.61 ATR from EMA21 · no notable pattern
- · Aligned with breakout_down (strong tailwind)
Options · swing
See more →
CALL
$640
2026-07-17
$20.60
PUT
$610
2026-07-17
$21.10
Insider activity
See more →No Form 4 filings in the last 30 days.
Earnings
See more →- Last reported
- 2026-04-29
- EPS (act / est)
- 6.75 / 8.60
- Surprise
- -21.5%
- Next report
- 2026-07-30
About
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide. The company develops product candidates to treat eye, allergic and inflammatory, cardiovascular, metabolic, neurological, infectious, and rare diseases; and cancer, hematologic conditions. It also offers EYLEA injections for wet age-relat…